Abiomed (ABMD) Receives FDA Approval for Impella RP System
January 27, 2015 at 16:15 PM EST
Abiomed Inc. (Nasdaq:ABMD) today announced that the Impella RP® (Right Percutaneous) System has received FDA approval under a Humanitarian Device Exemption (HDE). This innovative medical device is the first percutaneous single access heart pump designed for right heart support to receive FDA approval. Abiomed completed the HDE submission for the Impella RP in September 2014 […] View the full post at: Abiomed (ABMD) Receives FDA Approval for Impella RP System No related posts.